search
Key Ratio
USD
4.2
0.18 (4.5%)
NASDAQ:HBIO, HARVARD BIOSCIENCE, INC.
Industry: Medical Instruments & Supplies
End of Day: 27 March 2024 GMT-4

Income Statement Ratios

Fiscal

Gross Profit Margin
58.90%
Net Profit Margin (Adj.)
-2.60%
Return on Equity (Adj.)
0.900%
Fiscal (USD)
Period End Date
Financials
Revenue
Gross Profit
EBITDA
Operating Profit
Net Income (To Shareholders)
Net Income (Adj.)
Ratios
Gross Profit Margin
EBITDA Margin
Operating Margin
Net Profit Margin (Adj.)
Return on Equity (Adj.)
Return on Equity (Adj.) 3Y
Return on Equity (Adj.) 5Y
Return on Assets (Adj.)
Return On Invested Capital (Adj.)
ROIIC 3Y
ROIIC 10Y
Degree Of Op. Leverage (EBIT)
Degree Of Op. Leverage (CFO)
Rule Of 40 (EBITDA)
Rule Of 40 (FCF)
Per Share
Revenue / Share
Operating Profit / Share
Diluted EPS
Diluted EPS (Adj.)
FY23
31 Dec 2023
LTM23 Q4
31 Dec 2023
112
112
66.1
66.1
8.0
8.0
1.9
1.9
-3.4
-3.4
-1.6
-1.6
58.9%
58.9%
7.2%
7.2%
0.9%
0.9%
-2.6%
-2.6%
0.9%
0.9%
-1.1%
-1%
-1.1%
-0.8%
0.5%
0.5%
-0.07%
-0.07%
-9.1%
-9.1%
52.7%
-1.5%
-
-
-1,168x
-1,167x
6.2
6.2
9.5
9.5
2.6
2.6
0.04
0.04
-0.08
-0.08
-0.08
-0.08
In Millions except per share items.

Balance Sheet Ratios

Fiscal

Current Ratio
1.80x
Cash Ratio
0.200x
Total Debt to Equity Ratio
0.600x
Fiscal (USD)
Period End Date
Financials
Short Term Cash Investments
Total Assets
Total Debt
Total Liabilities
Total Equity
Ratios
Current Ratio
Cash Ratio
Total Debt to Equity Ratio
Net Debt (Cash) to Equity
Net Debt (Cash) to NTA
Cash Conversion Cycle
Avg Days Sales Out.
Avg Days Inventory Out.
Avg Days Payables Out.
Per Share
Total Assets / Share
Book Value/Share
Tangible Book Value / Share
Total Debt / Share
Cash / Share
Net Debt (Cash) / Share
FY23
31 Dec 2023
LTM23 Q4
31 Dec 2023
4.3
4.3
137
137
42.8
42.8
64.3
64.3
73.1
73.1
1.8x
1.8x
0.2x
0.2x
0.6x
0.6x
0.5x
0.5x
-1,426x
-1,426x
208
208
53.0
53.0
202
202
47.0
47.0
3.2
3.2
1.7
1.7
-0.0006
-0.0006
1.0
1.0
0.1
0.1
0.9
0.9
In Millions except per share items.

Cash Flow Ratios

Fiscal (USD, MM)

Cash From Operations
14
CAPEX
-2.3
Free Cash Flow (FCF)
11.7
Fiscal (USD)
Period End Date
Financials
CFO bef. W.C. Changes
Cash From Operations
CAPEX
Cash Flow From Investing
Cash Flow From Financing
Free Cash Flow (FCF)
Ratios
FCF Margin
Quality Of Earnings
Dividend Payout Ratio
Per Share
Cash From Operations / Share
Free Cash Flow / Share
Dividend / Share
Special Dividend / Share
FY23
31 Dec 2023
LTM23 Q4
31 Dec 2023
3.6
3.6
14.0
14.0
-2.3
-2.3
-1.8
-1.8
-12.1
-12.1
11.7
11.7
10.4%
10.4%
-
-
-
-
0.3
0.3
0.3
0.3
-
-
-
-
In Millions except per share items.

Valuation Ratios

Fiscal

Price / Sales
2.10x
Price / Earnings (Adj.)
-142.10x
Price / Tangible Book
-8,599.00x
Fiscal (USD)
Period End Date
Dividend Yield
Special Dividend Yield
Price / Sales
Price / Earnings (Adj.)
Price / Book
Price / Tangible Book
Price / CFO
Price / FCF
EV / EBIT
FY23
31 Dec 2023
LTM23 Q4
31 Dec 2023
-
-
-
-
2.1x
2.1x
-142.1x
-142.1x
3.2x
3.2x
-8,598x
-8,598x
16.5x
16.5x
19.8x
19.8x
120.3x
120.3x

Other Ratios

Fiscal (USD)
Period End Date
Revenue Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Operating Profit Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Net Income (Adj.) Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Diluted (Adj.) EPS Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Cash From Operations Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Free Cash Flow Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
FY23
31 Dec 2023
LTM23 Q4
31 Dec 2023
-1%
-1%
3.2%
3.2%
-1.5%
-1.5%
0.7%
0.7%
-
-
104.6%
104.6%
14.0%
14.0%
-6.4%
-6.4%
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1,118%
1,118%
14.6%
14.6%
37.2%
37.2%
13.2%
13.2%
-
-
12.7%
12.7%
44.2%
44.2%
17.3%
17.3%
Fiscal (USD)
Period End Date
Market Capitalization
Total Enterprise Value
Shares Outstanding
FY23
31 Dec 2023
LTM23 Q4
31 Dec 2023
187.8982m
187.8982m
227.8442m
227.8442m
43.3945m
43.3945m

  • Figures shown are in its reported currency unless stated otherwise.
  • Net Income and its respective ratios are normalised for one-off items unless stated otherwise.
  • PR = Press Release
  • FYC = Financial Year Change

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices